COMP <GO>
NOVT vs RTX // PIOTROSKI F-SCORE QUALITY
Novanta Inc. (NASDAQ) VS. RTX Corporation (NYSE) • 15-METRIC TALLY: NOVT 3
— RTX 12
▲ PIOTROSKI F-SCORE QUALITY LEADER: RTX
LAST: $145.76 (-3.59%) • MKT CAP: $5.72B
piotroski-score
7/9
LAST: $199.80 (+0.20%) • MKT CAP: $269.08B
piotroski-score
9/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NOVT VS. RTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NOVT | RTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.40% | 41.00% | +3.40 | NOVT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.50% | 7.20% | -0.70 | RTX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 51.7x | 26.5x | +25.20 | RTX | /valuation <GO> |
| Free Cash Flow Yield | 0.85% | 2.95% | -2.10 | RTX | /fcf-yield <GO> |
| Operating Margin | 9.60% | 10.50% | -0.90 | RTX | /operating-margins <GO> |
| Net Profit Margin | 5.50% | 7.60% | -2.10 | RTX | /net-margins <GO> |
| Revenue Growth (YoY) | 3.30% | 9.70% | -6.40 | RTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.33% | -1.33 | RTX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.30 | 2.73 | +5.57 | NOVT | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 9/9 | -2.00 | RTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.60% | +0.30 | RTX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 60.8 | -7.63 | RTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.92 | +0.09 | NOVT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 98.8x | 37.2x | +61.60 | RTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.72B | $269.08B | -$263.36B | RTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NOVT REV | RTX REV | NOVT GROSS % | RTX GROSS % | NOVT FCF | RTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $980.6M | $88.60B | 44.4% | 44.0% | $48.4M | $7.94B |
| FY 2024 | $949.2M | $80.74B | 44.4% | 44.0% | $141.3M | $4.53B |
| FY 2023 | $881.7M | $68.92B | 44.0% | 44.0% | $80.4M | $4.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NOVT // BETA 1.01
RTX // BETA 0.92